UPDATE
: Monday, December 9, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Column] Patient stabbed doctor to death -- things can’t just go on like this
Lim Se-won, a psychiatrist at Kanguk Samsung Hospital, died after a patient...
by Song Hyoung-gon
|
2019-01-03 14:58
라인
[Column] Buy expensive and waste your money?
On July 9, the Ministry of Food and Drug Safety banned the sale and manufac...
by Song Hyoung-gon
|
2018-07-16 15:09
라인
[Column]Nothing is cheap -- and good
On May 31, Korean Medical Association declared the breakdown of negotiation...
by Song Hyoung-gon
|
2018-06-05 11:47
라인
[Column]Brokerage reports and biotech stock prices
A local brokerage house issued a report named “Bio bubbles in small-medium ...
by Song Hyoung-gon
|
2018-04-20 17:29
라인
[Column] Look ahead 10 years before investing
It is said that waiting is the answer when it comes to new drugs that usual...
by Song Hyoung-gon
|
2017-12-13 17:48
라인
[Column] Trauma surgeon Lee, an oddball of lunatic energy
Ajou University Hospital’s regional trauma center officially opened on June...
by Song Hyoung-gon
|
2017-11-29 09:30
라인
[Column] Make haste slowly
It has already been 100 days since the inauguration of the new government o...
by Song Hyoung-gon
|
2017-08-30 11:52
라인
[Column]‘BIO 2017’ revealed Korean government’s absence of policy
I attended the “2017 BIO International Convention” held in San Diego, Calif...
by Song Hyoung-gon
|
2017-06-29 15:38
라인
[Column] Some thoughts on good manufacturing practice
In late February, I visited Ravensburg, Germany, to discuss the consignment...
by Song Hyoung-gon
|
2017-04-20 10:49
-
1
-
Korea selected as 'Medical Tourism Destination of the Year'
AbbVie's releases new data for chronic lymphocytic leukemia treatment
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Genematrix wins CE certification for respiratory disease virus detection kit
Korea selected as 'Medical Tourism Destination of the Year'
AbbVie's releases new data for chronic lymphocytic leukemia treatment
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Genematrix wins CE certification for respiratory disease virus detection kit
여백
Most viewed
1
Technology developed to detect inflammatory disorders early
2
'Insulin is safe, natural replacement therapy for diabetic patients'
3
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
4
Samyang Biopharm’s US subsidiary to work on new immunotherapy
5
Swedish researchers divide Type 2 diabetes into 5 subgroups
6
Ildong signs co-promotion contract with GSK Consumer Healthcare
7
Korean patient with rare breast cancer to sue Allergan in US
8
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
9
Korea exports health insurance system to Bahrain
10
Quick test for meningitis unavailable due to low reimbursement
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top